ABL Presented at World Vaccine Congress
ABL’s Associate Director of Product Development, Dr. Anthony Cristillo, presented at the World Vaccine Congress on April 17, 2013 titled “Increased Antibody Breadth Following Immunization with an HIV-1 Envelope-Based DNA Prime/Protein Boost Vaccine.” ABL scientists and business development staff attended (booth 612). ABL was also a nominee for CRO of the year.
The World Vaccine Congress is a yearly meeting of scientists and biotech professionals to discuss recent advances and discoveries in vaccine development. This year’s meeting is being held at the Gaylord National Resort and Convention Center in National Harbor, MD.
